Novel cytomegalovirus-inhibitory compounds of the class pyrrolopyridines show a complex pattern of target binding that suggests an unusual mechanism of antiviral activity

Hahn, F; Hutterer, C; Henry, C; Hamilton, ST; Strojan, H; Kraut, A; Schulte, U; Schutz, M; Kohrt, S; Wangen, C; Pfizer, J; Coute, Y; Rawlinson, WD; Strobl, S; Marschall, M

Marschall, M (reprint author), Schlossgarten 4, D-91054 Erlangen, Germany.

ANTIVIRAL RESEARCH, 2018; 159 (): 84

Abstract

Human cytomegalovirus (HCMV) is a major human pathogen with seropositivity rates in the adult population ranging between 40% and 95%. HCMV infection i......

Full Text Link